On the recordMay 20, 2019
We must strike this delicate balance with the policies that we pass through this committee to ensure that they do not dampen the success or deter future investment in biomedical research and innovation.
Source
congress.govEditor's note · Context
Burgess emphasizes the need for balanced policies to encourage biomedical investment.
Share
More from Michael Burgess
Dec 4, 2024
I reserve the balance of my time. Mr. McGOVERN. Mr. Speaker, I yield myself such time as I may consume. One of the bills that is being brought before us, H.R. 7198, is a Republican partisan bill, but it violates their own CutGo budgetary…
Jul 9, 2024
Last night, the Rules Committee met and reported out a rule, House Resolution 1341, providing for the consideration of five measures: H.R. 8281, Safeguard American Voter Eligibility Act; H.J. Res. 165, Providing for congressional…
Nov 13, 2024
Last week, the American people spoke forcefully against what we have seen for 4 years out of the Biden-Harris administration and their whole-of- government assault over individual freedom, economic prosperity, and limited government. For 4…
May 15, 2024
I thank my friend from New York for yielding, and I thank him for leading this discussion on behalf of the Rules Committee today. I wanted to come down and speak in support of the rule, and I want to speak in support of the underlying…
Other voices in this conversation
